SIA
BMY icon

SkyView Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

SkyView Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,121
Closed -$434K – 326
2025
Q1 		$434K Buy
+7,121
New +$415K 0.07% 210
2023
Q4 		– Sell
-693
Closed -$40K – 199
2023
Q3 		$40K Hold
693
– – 0.02% 291
2023
Q2 		$94K Sell
693
-7,640
-92% -$512K 0.02% 381
2023
Q1 		$578K Buy
8,333
+207
+3% +$14.6K 0.14% 192
2022
Q4 		$585K Sell
8,126
-474
-6% -$35.7K 0.18% 177
2022
Q3 		$611K Buy
8,600
+1,245
+17% +$90.3K 0.18% 186
2022
Q2 		$566K Buy
7,355
+2,805
+62% +$214K 0.15% 208
2022
Q1 		$353K Sell
4,550
-275
-6% -$18.5K 0.08% 309
2021
Q4 		$383K Buy
4,825
+1,303
+37% +$76.4K 0.09% 274
2021
Q3 		$208K Buy
3,522
+174
+5% +$11.5K 0.06% 324
2021
Q2 		$211K Hold
3,348
– – 0.1% 180
2021
Q1 		$211K Buy
3,348
+65
+2% +$4.04K 0.09% 188
2020
Q4 		$204K Buy
+3,283
New +$202K 0.1% 190

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SkyView Investment Advisors's BMY Position: Q2 2025 in Review

SkyView Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 7,121 shares — an estimated $434K sold.

SkyView Investment Advisors first reported a position in BMY in Q4 2020 and held it in 13 quarters. The position peaked at $611K in Q3 2022. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • SkyView Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • SkyView Investment Advisors sold 7,121 Bristol-Myers Squibb shares in Q2 2025, an estimated $434K.
  • SkyView Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 13 quarters.
  • SkyView Investment Advisors's Bristol-Myers Squibb position peaked at $611K in Q3 2022.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on SkyView Investment Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.